Literature DB >> 8652592

Regulation of HIV-1 protease activity through cysteine modification.

D A Davis1, K Dorsey, P T Wingfield, S J Stahl, J Kaufman, H M Fales, R L Levine.   

Abstract

The homodimeric protease of the human immunodeficiency virus 1 contains two cysteine residues per monomer which are highly conserved among viral isolates. However, these cysteine residues are not essential for catalytic activity which raises the question of why they are conserved. We have found previously that these cysteine residues are unusually susceptible to oxidation by metal ions, and this results in inhibition of protease activity. Recombinant protease mutants (C67A, C95A, and the double mutant C67A,C95A) were prepared to assess the possible role of these cysteines in redox regulation of the enzyme. Mixed disulfides were formed between the cysteine residues of the enzymes and low molecular weight thiols. Enzyme activity was lost when a mixed disulfide was formed between 5,5'-dithiobis(2-nitrobenzoic acid) and cysteine 95, while the same mixed disulfide at cysteine 67 reduced activity by 50%. This effect was reversible as normal activity could be restored when the enzyme was treated with dithiothreitol. The cysteines could also be modified with the common cellular thiol glutathione. Modification with glutathione was verified by mass spectrometry of the protein peaks obtained from HPLC separation. Glutathiolation of cysteine 95 abolished activity whereas modification at cysteine 67 increased the k(cat) by more than 2-fold with no effect on K(m). In addition, glutathiolation at cysteine 67 markedly stabilized the enzyme activity presumably by reducing autoproteolysis. These results demonstrate one possible mechanism for regulation of the HIV-1 protease through cysteine modification and identify additional targets for affecting protease activity other than the active site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652592     DOI: 10.1021/bi951525k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes.

Authors:  Maddalena Fratelli; Hans Demol; Magda Puype; Simona Casagrande; Ivano Eberini; Mario Salmona; Valentina Bonetto; Manuela Mengozzi; Francis Duffieux; Emeric Miclet; Angela Bachi; Joel Vandekerckhove; Elisabetta Gianazza; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Exploring key orientations at protein-protein interfaces with small molecule probes.

Authors:  Eunhwa Ko; Arjun Raghuraman; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2012-12-27       Impact factor: 15.419

3.  Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.

Authors:  Niki L Reynaert; Albert van der Vliet; Amy S Guala; Toby McGovern; Milena Hristova; Cristen Pantano; Nicholas H Heintz; John Heim; Ye-Shih Ho; Dwight E Matthews; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

4.  Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.

Authors:  R W Humphrey; A Ohagen; D A Davis; T Fukazawa; H Hayashi; S Höglund; H Mitsuya; R Yarchoan
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophages.

Authors:  David A Davis; Elizabeth Read-Connole; Kara Pearson; Henry M Fales; Fonda M Newcomb; Jackob Moskovitz; Robert Yarchoan
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

6.  Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach.

Authors:  David A Davis; Irene R Tebbs; Sarah I Daniels; Stephen J Stahl; Joshua D Kaufman; Paul Wingfield; Michael J Bowman; Jean Chmielewski; Robert Yarchoan
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

Review 7.  S-glutathionylation: from redox regulation of protein functions to human diseases.

Authors:  Daniela Giustarini; R Rossi; A Milzani; R Colombo; Isabella Dalle-Donne
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

8.  Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions.

Authors:  D A Davis; K Yusa; L A Gillim; F M Newcomb; H Mitsuya; R Yarchoan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Thioltransferase activity of bovine lens glutathione S-transferase.

Authors:  M Dal Monte; I Cecconi; F Buono; P G Vilardo; A Del Corso; U Mura
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

Review 10.  Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.

Authors:  Melissa D Shelton; John J Mieyal
Journal:  Mol Cells       Date:  2008-05-16       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.